Literature DB >> 16602456

Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran.

Z M Amiri1, A J Shakib, M Toorchi.   

Abstract

We assessed the prevalence of hepatitis C virus (HCV) infection and associated risk factors for all 298 haemodialysis patients in 7 dialysis units in Guilan province. Serum samples were screened for anti-HCV antibodies using a second generation enzyme-linked immunosorbent assay. Positive samples were confirmed by immunoblot assay. Overall prevalence was 24.8% (range: 9%-40%; 95% CI: 19.9-29.7): 80 patie.nts tested positive and 74 were confirmed positive by immunoblot assay. Length of time on dialysis and history of rejected kidney transplant were statistically significantly associated with HCV infection. Age, sex and previous blood transfusion were not associated. Nosocomial transmission may play a role in the spread of HCV in haemodialysis units. A separate dialysis system should be used for seropositive HCV patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16602456

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  13 in total

Review 1.  Management of hepatitis C in patients with chronic kidney disease.

Authors:  Mohammad A B Al-Freah; Zeino Zeino; Michael A Heneghan
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 2.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 3.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

5.  A shield against a monster: Hepatitis C in hemodialysis patients.

Authors:  Seyed-Moayed Alavian
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

6.  Surveillance system for hepatitis C infection: A practical approach.

Authors:  Najmeh Jafari; Ziba Farajzadegan; Behrooz Ataei
Journal:  Int J Prev Med       Date:  2012-03

7.  Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran.

Authors:  Ali Kargar Kheirabad; Fahime Bahri; Mohammad Kargar; Iman Ghasemzadeh
Journal:  Hepat Mon       Date:  2016-08-13       Impact factor: 0.660

Review 8.  The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses.

Authors:  Sarwat Mahmud; Vajiheh Akbarzadeh; Laith J Abu-Raddad
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

Review 9.  Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis.

Authors:  Nahid Ramezan Ghorbani; Shirin Djalalinia; Mitra Modirian; Zahra Esmaeili Abdar; Morteza Mansourian; Armita Mahdavi Gorabi; Hamid Asayesh; Hossein Ansari; Mehrdad Kazemzadeh Atoofi; Ramin Tajbakhsh; Mehdi Noroozi; Saeid Safiri; Mostafa Qorbani
Journal:  J Res Med Sci       Date:  2017-11-28       Impact factor: 1.852

Review 10.  Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review.

Authors:  Jonathan Aguirre Valadez; Ignacio García Juárez; Rodolfo Rincón Pedrero; Aldo Torre
Journal:  Ther Clin Risk Manag       Date:  2015-02-27       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.